Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemisia Annua SLIT in Seasonal Allergic Rhinitis
NCT03649139Phase 3Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Artemisia annua SLIT with Placebo (2 arms). Primary endpoint: Change from baseline symptom scores at Week 16. Started Apr 2017; status: completed.
02
Drugs
Artemisia annua pollen allergen sublingual drops
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03649139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649139.